Patrick M. Sweeney & Associates’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
VCM
VPM
Patrick M. Sweeney & Associates's ELV Position: Q1 2026 in Review
Patrick M. Sweeney & Associates increased its Elevance Health (ELV) stake by 1.2% in Q1 2026, buying an estimated $4.93K and bringing the position to 1,310 shares worth $383K. The position accounts for 0.25% of the portfolio, ranked #105.
Patrick M. Sweeney & Associates first reported a position in ELV in Q4 2023 and has held it in 10 quarters since. The position peaked at $685K in Q3 2024. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- Patrick M. Sweeney & Associates held 1,310 shares of Elevance Health worth $383K as of Q1 2026.
- Patrick M. Sweeney & Associates bought 15 Elevance Health shares in Q1 2026, an estimated $4.93K.
- Elevance Health made up 0.25% of Patrick M. Sweeney & Associates's portfolio in Q1 2026, its #105 holding.
- Patrick M. Sweeney & Associates first reported a position in Elevance Health in Q4 2023 and has held it in 10 quarters since.
- Patrick M. Sweeney & Associates's Elevance Health position peaked at $685K in Q3 2024.
- 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on Patrick M. Sweeney & Associates's 13F filing for Q1 2026, filed 7 May 2026.